Recent Updates — AVTR
Avantor reported third-quarter 2026 net sales of $1,698.3 million, a 4.6% increase from the prior year period, driven by organic growth of 5.2%. Diluted GAAP earnings per share were $0.30, compared to a loss of $1.04 in the same quarter last year, while adjusted diluted EPS was $0.22. The company also raised its full-year fiscal 2026 guidance for organic revenue growth to +0.75% to +1.25%, adjusted EPS to $0.81–$0.83, and free cash flow to $525M–$550M. Avantor is a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries.
Avantor, Inc. appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner succeeds Steven Eck in the CFO role, while Eck continues as Senior Vice President and Chief Accounting Officer. Garner’s compensation includes a $700,000 annual base salary, an 80% target bonus, a $150,000 signing bonus, and a $1,500,000 initial equity grant split between restricted stock units and stock options. Avantor is a global provider of mission-critical products and services to the life sciences and advanced technology industries.
Avantor, Inc. appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner succeeds Steven Eck in the CFO role while Eck continues as Senior Vice President and Chief Accounting Officer. Garner’s compensation includes a $700,000 annual base salary, an 80% target bonus, a $150,000 signing bonus, and a $1,500,000 initial equity grant split between restricted stock units and stock options. Avantor operates in the life sciences supply chain industry.
Avantor reported second quarter 2026 net sales of $1,692.3 million and diluted GAAP EPS of $0.06. The company updated its full-year fiscal 2026 guidance, raising the organic revenue growth range to -0.5% to +0.5% from a previous forecast of -2.5% to -0.5%, while maintaining adjusted EPS guidance at $0.80 to $0.83. Management highlighted improved performance in the VWR Distribution and Services segment, which returned to positive organic growth ahead of schedule. Avantor operates as a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries.
On July 14, 2026, Avantor Funding, Inc., a subsidiary of Avantor, Inc., entered into Amendment No. 15 to its Credit Agreement to obtain €374,208,296.62 in senior secured Euro-denominated term loans (Incremental B-7 Euro Term Loans). These loans, maturing October 9, 2032, carry an interest rate of the floating EURIBOR Rate plus 2.00% per annum, effectively refinancing existing euro term loans that carried a higher spread of 2.50%. The new loans are secured by the same collateral and guaranteed by the same subsidiaries as the existing credit facilities. Avantor operates in the life sciences industry, providing products and services to customers in the biopharma, healthcare, education, and government sectors.